The eNose Company

medical devices

About

The current organization of the eNose Company was founded in 2013. The eNose Company is mainly focused on exhaled breath analysis of patiënts for disease screening. After a number of pilot- studies in oncology, infectional- and neurological diseases, the eNose Company is fully focused on certain indications like Lung Cancer, Colon Cancer, Barrett's E., Lung embolism, Multiple Sclerose and Tuberculosis. Recently, we validated Lung Cancer by a multicenter validation study, and it will be the first indication with full clinical evidence based on the thesis of Lung physician Dr. S.Kort: "detection of lung cancer in exhaled breath with electronic nose technology"

Technologies

Outlook WordPress.org reCAPTCHA Apache Vimeo Mobile Friendly Google Tag Manager Google Analytics

Keywords

breath analysis breath screening breath diagnosis olfactory diagnosis early detection of infectious diseases medical device certification patient safety diagnostic software portable diagnostic device patient-friendly diagnostic accuracy improvement clinical validation healthcare data security voc biomarkers machine learning medical research publications medical devices biomarker analysis diagnostic accuracy non-invasive breath test voc detection lung cancer breath test tuberculosis breath screening validation studies early disease detection colorectal cancer detection healthcare equipment & supplies medical research medical device development non-invasive diagnostics

Location

85 Industrieweg, Zutphen, Gelderland, Netherlands, 7202 CA

Related Companies

Companies in the same industry